Tuesday, February 09, 2021 8:47:23 AM
February 9, 2021 at 6:00 AM EST
https://ir.tilray.com/news-releases/news-release-details/tilrayr-announces-agreement-grow-pharma-import-and-distribute
Grow Pharma will distribute Tilray’s GMP-certified medical cannabis products across the UK
New UK agreement gives doctors and patients access to a sustainable supply of Tilray’s pharmaceutical-grade medical cannabis products
NANAIMO, British Columbia--(BUSINESS WIRE)--Feb. 9, 2021-- Tilray Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has established an agreement with Grow Pharma to import and distribute Tilray’s medical cannabis products into the United Kingdom (UK). This agreement allows Tilray to provide authorized UK patients in need with a locally maintained supply of medical cannabis solutions.
Tilray expects to have a range of GMP-certified, medical cannabis products available for patients in the UK by March 2021. Patients looking to use medical cannabis will have access to Tilray products in the UK by obtaining prescriptions through private practice or the National Health Service (NHS).
Brendan Kennedy, Tilray’s Chief Executive Officer, said, “This partnership with Grow Pharma provides patients in need access to a sustained supply of GMP-certified, high-quality medical cannabis and is an important step in improving access in the UK. Tilray will continue to advocate for reasonable patient access to medical cannabis in Europe and countries around the world.”
Sascha Mielcarek, Managing Director of Tilray Europe, said, “As demand continues to ramp up in the UK, Tilray is well-positioned to be a leading supplier of medical cannabis products. Regulations are progressing as more and more countries across Europe are recognizing the benefits of medical cannabis and its potential to improve patients’ quality of life. We’re pleased to reaffirm our commitment to delivering medical cannabis to patients in the UK and look forward to offering a variety of GMP-certified, pharmaceutical-grade products in the coming months.”
Pierre van Weperen, Chief Executive Officer of Grow Pharma, said, “We’re proud to join forces with Tilray and provide patients in need with a secure and sustainable supply of the highest-quality medical cannabis products in the UK.”
About Grow Pharma
Grow Pharma is a leading UK medical cannabis distributor, part of the Grow Group. Grow Group PLC exists to unlock the medical potential of cannabis for those who need it though three business units: Grow Pharma, Grow Trading and Grow Biotech. Grow Pharma works with the producers of the best cannabis-based medicines and helps them introduce their products in new markets like the U.K. and Ireland, creating long-term value for them and offering solutions for patients. The Grow Pharma team also focuses on supporting clinics and individual healthcare professionals and through our partnership with IPS Specials Pharma we work with the best importer, distributor and pharmacy in the country to deliver the medication to patients. Ultimately, all Grow Group activities are aimed at improving patient access to cannabis medicines. https://growgroupplc.com
About Tilray®
Tilray is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 17 countries spanning five continents.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of Canadian securities laws, or collectively, forward-looking statements. Forward-looking statements in this press release may be identified by the use of words such as, "may", "would", "could", "will", "likely", "expect", "anticipate", "believe, "intend", "plan", "forecast", "project", "estimate", "outlook" and other similar expressions. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions, and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including assumptions in respect of current and future European market conditions, the current and future regulatory environment and future approvals and permits. Actual results, performance, or achievement could differ materially from that expressed in, or implied by, any forward-looking statements in this press release, and, accordingly, you should not place undue reliance on any such forward-looking statements, and they are not guarantees of future results. Please see the heading "Risk Factors" in Tilray's Quarterly Report on Form 10-Q, which was filed with the Securities and Exchange Commission on November 9, 2020, for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. Tilray does not undertake to update any forward-looking statements that are included herein, except in accordance with applicable securities laws.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005404/en/
Tilray Global:
Berrin Noorata
news@tilray.com
To request an interview opportunity:
Media
Amy Bonwick
647-515-3748
amy@pomppr.com
Ranjit Dhatt
647-890-2445
ranjit@pomppr.com
Investors
Raphael Gross
203-682-8253
Raphael.Gross@icrinc.com
Source: Tilray Inc.
Recent TLRY News
- Tilray Beverages Announces Campaign to Raise Awareness for Men’s Health • GlobeNewswire Inc. • 06/14/2024 11:00:00 AM
- Embrace the Spirit of Summer and Create Shareable Moments with Good Supply Cannabis • GlobeNewswire Inc. • 06/12/2024 11:00:00 AM
- Breckenridge Distillery Wins Double Gold for a Consecutive Year in a Row at the 2024 New York International Spirits Competition • GlobeNewswire Inc. • 06/06/2024 11:30:00 AM
- Redecan Cannabis Introduces New Top Shelf Flower 'Purple Churro' • GlobeNewswire Inc. • 06/06/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 10:36:34 PM
- Twist Your Tastebuds Three Ways: Good Supply Cannabis Brand Launches ‘Twisted’ All-In-One Vapes • GlobeNewswire Inc. • 05/30/2024 11:00:00 AM
- Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’ • GlobeNewswire Inc. • 05/23/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 12:00:18 PM
- Tilray Brands Announces At-The-Market Program to Fund Strategic and Accretive Acquisitions and Accelerate Expansion Plan Upon U.S. Cannabis Rescheduling When Effective • GlobeNewswire Inc. • 05/17/2024 11:45:49 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/17/2024 11:35:52 AM
- SweetWater Brewing Launches New Sunset Sippin’ Cocktail Inspired Hard Seltzers • GlobeNewswire Inc. • 05/16/2024 11:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/14/2024 08:05:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:00:34 AM
- Breckenridge Brewery Announces On Tap with KBCO Concert Series Featuring Cannons, The Moss and Dehd • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:00:46 AM
- 10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series • GlobeNewswire Inc. • 05/03/2024 11:07:37 AM
- Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Breckenridge Brewery Introduces New West Coast Style IPA ‘Ridge Runner’ • GlobeNewswire Inc. • 04/29/2024 11:00:00 AM
- Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World • GlobeNewswire Inc. • 04/25/2024 08:33:50 PM
- Tilray Brands Celebrates Epic 420 Weekend With Over 20,000 Fans Across the U.S. • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Sweetwater Brewing Unveils Modern Rebrand • GlobeNewswire Inc. • 04/25/2024 11:00:00 AM
- Good Supply Cannabis Introduces New Signature ‘Bud Squad’ Products • GlobeNewswire Inc. • 04/24/2024 11:00:00 AM
- Montauk Brewing’s Project 4:20 IPA Returns to Support Surfrider Foundation • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- Good Supply Cannabis Brand Celebrates Earth Day and Unveils Environmental Impact of “Green You Can Feel Good About” Campaign • GlobeNewswire Inc. • 04/18/2024 11:00:00 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM